11th ASM Conference on Candida and candidiasis

第 11 届 ASM 念珠菌和念珠菌病会议

• 批准号: 8257412
• 负责人: Scott G Filler
• 金额: $ 0.7万
• 依托单位: AMERICAN SOCIETY FOR MICROBIOLOGY
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-03-01 至 2013-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8257412
• 关键词: AIDS/HIV problem; Achievement; Acquired Immunodeficiency Syndrome; Affect; Agreement; American; Antifungal Agents; Apoptosis; Area; Azoles; Candida; Candida albicans; Candida glabrata; Candidiasis; Cell Communication; Chemotherapy-Oncologic Procedure; Cities; Clinical; Collaborations; Communicable Diseases; Communities; Community Developments; Cytolysis; Development; Diagnosis; Disease; Disseminated candidiasis; Drug resistance; Educational workshop; Effectiveness; Epidemiology; Epigenetic Process; Esophageal; Failure; Feedback; Filler; Financial Support; Frequencies; Funding; Fungal Drug Resistance; Genes; Genome; Genomics; Goals; Growth; Guidelines; Healthcare; Host Defense; Human; Imagination; Immune; Immune response; Immunocompetent; Immunocompromised Host; Immunology; In Vitro; Individual; Infection; International; Lead; Life; Medical; Metabolism; Methods; Microbial Biofilms; Microbiology; Minority; Modeling; Molecular; Morphogenesis; Neonatal Intensive Care Units; Oral; Oropharyngeal; Participant; Partner in relationship; Pathogenicity; Patients; Premature Infant; Prophylactic treatment; Proteomics; Psyche structure; Publications; Recording of previous events; Research; Research Personnel; Resources; Rodent Model; Role; San Francisco; Scientist; Screening procedure; Series; Signal Transduction; Societies; Surveys; Systems Biology; Techniques; Technology; The science of Mycology; Time; Training; Vaccines; Vagina; Woman; abstracting; base; candidemia; career; flexibility; fungus; genome sequencing; in vivo; in vivo Model; interest; meetings; member; mutant; new technology; pathogen; posters; prevent; programs; resistance mechanism; response; success; symposium; therapeutic vaccine; tool; AIDS/HIV problem; Achievement; Acquired Immunodeficiency Syndrome; Affect; Agreement; American; Antifungal Agents; Apoptosis; Area; Azoles; Candida; Candida albicans; Candida glabrata; Candidiasis; Cell Communication; Chemotherapy-Oncologic Procedure; Cities; Clinical; Collaborations; Communicable Diseases; Communities; Community Developments; Cytolysis; Development; Diagnosis; Disease; Disseminated candidiasis; Drug resistance; Educational workshop; Effectiveness; Epidemiology; Epigenetic Process; Esophageal; Failure; Feedback; Filler; Financial Support; Frequencies; Funding; Fungal Drug Resistance; Genes; Genome; Genomics; Goals; Growth; Guidelines; Healthcare; Host Defense; Human; Imagination; Immune; Immune response; Immunocompetent; Immunocompromised Host; Immunology; In Vitro; Individual; Infection; International; Lead; Life; Medical; Metabolism; Methods; Microbial Biofilms; Microbiology; Minority; Modeling; Molecular; Morphogenesis; Neonatal Intensive Care Units; Oral; Oropharyngeal; Participant; Partner in relationship; Pathogenicity; Patients; Premature Infant; Prophylactic treatment; Proteomics; Psyche structure; Publications; Recording of previous events; Research; Research Personnel; Resources; Rodent Model; Role; San Francisco; Scientist; Screening procedure; Series; Signal Transduction; Societies; Surveys; Systems Biology; Techniques; Technology; The science of Mycology; Time; Training; Vaccines; Vagina; Woman; abstracting; base; candidemia; career; flexibility; fungus; genome sequencing; in vivo; in vivo Model; interest; meetings; member; mutant; new technology; pathogen; posters; prevent; programs; resistance mechanism; response; success; symposium; therapeutic vaccine; tool

DESCRIPTION: Candida is the major fungal pathogen of humans, causing diseases that range from oral and vaginal candidiasis to life-threatening candidemia and invasive disease. The Candida field focuses on a broad spectrum of subjects that relate to epidemiology, drug resistance, infection, host response, vaccines and therapeutics. The Candida and Candidiasis Conference, held every two years, is the premier forum for the presentation of cutting-edge advances and the latest perspectives in these diverse areas. Funds are requested to provide partial support for the 11th Conference on Candida and Candidiasis, which will be held from March 29 to April 2, 2012, in San Francisco, CA. The conference will be sponsored by the American Society for Microbiology, which will provide both management expertise and financial support. The program will be based upon past conferences of the series, which have reliably drawn attendance of over 450 American and International scientists, and have been met with enthusiastic support in participant surveys. This program will include 38 speakers who will be chosen for their expertise in fundamental and/or clinical mycology and 48 speakers who will be selected based on submitted abstracts. This arrangement will provide the flexibility to present cutting-edge advances and to enlist a diverse spectrum of emerging and established community members as speakers. There will be clinical talks about the epidemiology, diagnosis, and treatment of candidiasis, with speakers carefully prescreened for affability and effectiveness. These talks will be incorporated into sessions that focus on various key aspects of candidal infections, including environmental signaling, systems biology, antifungal agents and resistance, immune recognition, vaccines, morphogenesis, and biofilms. There will be two lunch sessions in which the strengths and weakness of various experimental rodent models of candidiasis will be discussed by both basic scientists and clinicians. In addition, there will be concurrent sessions on fungal metabolism, new technologies, epigenetics, and apoptosis to further encourage productive interaction and discussion. Each afternoon, there will be a poster session so that a total of 250-300 posters will be presented. We are confident that our goals - to present the latest advances in the field, to spotlight achievements of junior scientists (especially women and minorities), to promote synergistic and interdisciplinary interactions, and to provide a venue for community-wide discussion - will be achieved. PUBLIC HEALTH RELEVANCE: Candida is the major fungus that causes infectious disease, affecting AIDS patients, cancer chemotherapy patients, premature infants, and many others. The 12th Conference on Candida and Candidiasis will provide a forum for the Candida research community to present the most recent advances and ideas, covering a broad spectrum of subjects from clinical issues to molecular mechanisms, from growth of the fungus to response of the host. The conference will help chart the course of future research and facilitate the urgent necessity to understand, treat, and prevent disease.

描述： 念珠菌是人类的主要真菌病原体，引起疾病，从口腔和阴道念珠菌病到威胁生命的念珠菌和侵入性疾病。念珠菌场的重点是与流行病学，耐药性，感染，宿主反应，疫苗和治疗学有关的广泛受试者。每两年举行一次念珠菌和念珠菌会议，是介绍前沿进步和这些不同领域的最新观点的主要论坛。要求资金为第11届念珠菌和念珠菌病提供部分支持，该会议将于2012年3月29日至2012年4月2日在加利福尼亚州旧金山举行。会议将由美国微生物学会赞助，该学会将提供管理专业知识和财务支持。该计划将基于该系列的过去会议，这些会议可靠地吸引了450多名美国和国际科学家，并在参与者的调查中得到了热情的支持。该计划将包括38位演讲者，他们将因其基本和/或临床真菌学方面的专业知识而被选为48位演讲者，他们将根据提交的摘要进行选择。这种安排将提供灵活性，以展现最先进的进步，并以演讲者的身份吸引各种各样的新兴和建立的社区成员。关于念珠菌病的流行病学，诊断和治疗的临床谈判，仔细预先筛选了有关伴侣和有效性的说话者。这些会谈将 将集中在候选感染的各个关键方面的会议上，包括环境信号传导，系统生物学，抗真菌剂和抗药性，免疫识别，疫苗，形态发生和生物膜。基础科学家和临床医生将讨论两次午餐会议，其中各种实验性啮齿动物模型的优势和劣势将讨论。此外，还将举办关于真菌代谢，新技术，表观遗传学和凋亡的并发会议，以进一步鼓励生产性的互动和讨论。每天下午，都会有一个海报会议，以便总共介绍250-300张海报。我们有信心我们的目标 - 呈现最新的 将在该领域的进步，促进初级科学家（尤其是妇女和少数民族）的成就，以促进协同和跨学科的互动，并为社区范围的讨论提供场地。 公共卫生相关性： 念珠菌是引起传染病，影响艾滋病患者，癌症化学疗法患者，早产婴儿等的主要真菌。第十二届念珠菌和念珠菌病将为念珠菌研究社区提供一个论坛，以提出最新进展和思想，涵盖从临床问题到分子机制的各种受试者，从真菌的增长到宿主的反应。该会议将有助于绘制未来研究的过程，并促进理解，治疗和预防疾病的迫切必要性。